A 52-week, randomized, double-blind, placebo-controlled,

Project: Research project

Project Details

Description

A 52-week, randomized, double-blind, placebo-controlled, multi-center, parallel-group study of ...Agomelatine
StatusFinished
Effective start/end date1/1/073/31/10

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.